PainReform Ltd. (PRFX) Short-Term Debt to Capital

PainReform Ltd. - graphic logo of issuer PRFX

PainReform Ltd. (PRFX) maintains an impeccable reputation among surgeons due to its innovations. This price chart, where the indicator equals 0.00, links the success of the final PRF-110 trials and the FDA filing to future earnings. The company's revenues rely on the commercialization of slow-release analgesic injections, which will ensure effective postoperative pain management.

PainReform Limited (PRFX) Ratio of Short-Term Indebtedness to Capital: for the period 07/04/2022 - 10/28/2026

Metric breakdowns and analytics for painreform.com (PRFX)

- price and consensus price forecast:
Stock Price PainReform Limited|PRFX - Fair Value Consensus
- market capitalization data:
Market Capitalization PainReform Ltd|PRFX - Enterprise Value
- book capitalization data:
Net Assets per Single Share PainReform|PRFX - Accounting Value of Company|Market Value to Book Value Ratio painreform.com|PRFX - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital PainReform Ltd.|PRFX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio PainReform|PRFX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio PainReform Ltd|PRFX - Long-Term Debt|Company Current Liabilities PainReform
General company analysis:PainReform Limited (PRFX)
Brand item of PainReform Ltd

Anticipation of FDA approval for PRF-110 drives the price action of the short-term loan-to-equity ratio chart, where the ratio of liabilities with a maturity exceeding one year to equity measures the ability of PainReform Ltd. (PRFX) to fund development without risking insolvency. The decline of this coefficient confirms balance sheet resilience in the absence of revenue, signaling to investors a minimization of debt load while preparing for commercialization.

Competitors of PainReform Ltd.

Haleon Group (HLN) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Kenvue Health (KVUE)|Short-Term Debt to Capital VRNA (Verona Pharma plc)|jyongbio.com - Short-Term Debt to Capital|Short-Term Debt to Equity Ligand (LGND)|AMRX: Ratio of Short-Term Indebtedness to Capital|PRGO (Perrigo Company) - Short-Term Debt to Equity|Alvotech Biopharmaceuticals (ALVO) - Short-Term Debt to Equity Ratio|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com (GLPG)|ANI Pharmaceuticals, Inc. (ANIP) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital MNKD (MannKind Corp)|AMPH: Short-Term Debt to Equity|PCRX - Current Liabilities to Capital|Short-Term Debt to Equity Ratio ARS Pharmaceuticals SPRY|TBPH - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital Aquestive Therapeutics, Inc. AQST|scPharmaceuticals (SCPH) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TECX (Tectonic Therapeutic Inc.)|Current Liabilities to Capital TNXP|China SXT Pharmaceuticals (SXTC) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital EPRX (eupraxiapharma.com)|BioHarvest Sciences Inc. (BHST) - Short-Term Debt to Equity|Current Liabilities to Equity Invizyne Technologies EXOZ|Oramed Pharma - Short-Term Debt to Capital|ENTX - Short-Term Debt to Capital|MindWalk Holdings - Short-Term Debt to Capital|ABVC (abvcpharma.com) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Cumberland Pharmaceuticals Inc. (CPIX)|Short-Term Debt to Capital Ratio QNTM|FibroGen Corp (FGEN) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Telomir Pharmaceuticals Corp (TELO)|RANI: Short-Term Debt to Capital|Current Liabilities to Capital Synergy CHC Corp. SNYR|Short-Term Debt to Capital Rallybio Corp.|LEXX: Current Liabilities to Equity|Short-Term Debt to Equity PULM|PTHL (Pheton Holdings) - Current Liabilities to Capital|APM - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital LYRA|Short-Term Debt to Equity IBO (Impact BioMedical)|Short-Term Debt to Equity Ratio tnfpharma.com TNFA|Short-Term Debt to Equity Ratio cbdMD|Altamira Therapeutics Ltd - Ratio of Short-Term Indebtedness to Capital|LIPO - Short-Term Debt to Equity|optinose.com (OPTN) - Short-Term Debt to Equity|PIRS - Short-Term Debt to Equity Ratio|Procaps Group (PROC) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital Petros (PTPI)|Short-Term Debt to Capital Ratio Qilian International Corp (QLI)|SLRN (Acelyrin, Inc.) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient TFFP (tffpharma.com)